CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
San Antonio, Texas, United States and 43 other locations
dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivot...
Phase 2
San Antonio, Texas, United States and 72 other locations
The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...
Phase 3
San Antonio, Texas, United States and 156 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
San Antonio, Texas, United States and 335 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
San Antonio, Texas, United States and 146 other locations
The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma a...
Phase 3
San Antonio, Texas, United States and 17 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
San Antonio, Texas, United States and 137 other locations
Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...
Phase 2
San Antonio, Texas, United States and 14 other locations
PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...
Phase 2
Boerne, Texas, United States and 136 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
San Antonio, Texas, United States and 83 other locations
Clinical trials
Research sites
Resources
Legal